COPD-话题@MedSci

#COPD#

31篇内容 | 4018人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1189408, encodeId=83041189408bb, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>慢性病管理。, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=120, createdTime=2022-01-31, rootId=0, userName=moyanju2796, userId=cbcd5675699, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1185250, encodeId=72411185250e6, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>学习, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=111, createdTime=2022-01-17, rootId=0, userName=ms3000002057134316, userId=3da35408927, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1081008, encodeId=d693108100834, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>随访，规范治疗。, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=110, createdTime=2021-12-17, rootId=0, userName=moyanju2796, userId=cbcd5675699, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1076721, encodeId=1db310e6721c8, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>发病率很高。规范治疗的很少。, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=109, createdTime=2021-12-04, rootId=0, userName=moyanju2796, userId=cbcd5675699, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1071908, encodeId=3f3710e190806, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>新版指南更新啦, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=111, createdTime=2021-11-19, rootId=0, userName=啦啦啦一只小猪, userId=d1c82325117, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1063279, encodeId=79d310632e937, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>肺性脑病, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=114, createdTime=2021-10-23, rootId=0, userName=云舒, userId=3cff5430616, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1011334, encodeId=d88d101133458, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>学习, objectTitle=2021 AAFP临床实践指南：COPD急性加重的药物治疗, objectType=guider, longId=14024, objectId=8b0b21c0021385ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=8b0b21c0021385ef, replyNumber=0, likeNumber=134, createdTime=2021-08-25, rootId=0, userName=贝宝聂是念来过倒5, userId=881d5584286, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b0b21c0021385ef, moduleTitle=2021 AAFP临床实践指南：COPD急性加重的药物治疗, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=8b0b21c0021385ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=968775, encodeId=2553968e75bb, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>布地奈德, objectTitle=COPD, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606820853683_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=135, createdTime=2021-05-26, rootId=0, userName=smart Ren, userId=b3545492917, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=799789, encodeId=ab92e9978915, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>320或160μg布地奈德+18μg格隆溴铵+9.6μg沙美特罗, objectTitle=NEJM：含布地奈德的三联方案可有效控制中重度COPD进展, objectType=article, longId=196474, objectId=bdfa1964e434, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020625/1593052717433_2051781.jpg, objectUrl=/article/show_article.do?id=bdfa1964e434, replyNumber=1, likeNumber=228, createdTime=2020-06-25, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdfa1964e434, moduleTitle=NEJM：含布地奈德的三联方案可有效控制中重度COPD进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdfa1964e434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=896299, encodeId=2a6d89629929, content=含<a href='/topic/show?id=a08a4840288' target=_blank style='color:#2F92EE;'>#布地奈德#</a>的三联方案可有效控制中重度<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>进展，未来LABA+LAMA方案应该是主流, objectTitle=NEJM：含布地奈德的三联方案可有效控制中重度COPD进展, objectType=article, longId=196474, objectId=bdfa1964e434, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020625/1593052717433_2051781.jpg, objectUrl=/article/show_article.do?id=bdfa1964e434, replyNumber=0, likeNumber=230, createdTime=2020-11-02, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdfa1964e434, moduleTitle=NEJM：含布地奈德的三联方案可有效控制中重度COPD进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdfa1964e434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=602020, encodeId=81ef602020a3, content=<a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a>这是很好理解的, objectTitle=, objectType=topic, longId=5086, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=151, createdTime=2020-06-11, rootId=0, userName=神盾医疗局局长Jack, userId=ab235268530, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

COPD

2020-05-29

moyanju2796 (审核中...)

前往app查看评论内容

#COPD#慢性病管理。

2022-01-31

ms3000002057134316 (审核中...)

前往app查看评论内容

#COPD#学习

2022-01-17

moyanju2796 (审核中...)

前往app查看评论内容

#COPD#随访，规范治疗。

2021-12-17

moyanju2796 (审核中...)

前往app查看评论内容

#COPD#发病率很高。规范治疗的很少。

2021-12-04

啦啦啦一只小猪 (审核中...)

前往app查看评论内容

#COPD#新版指南更新啦

2021-11-19

云舒 (审核中...)

前往app查看评论内容

#COPD#肺性脑病

2021-10-23

贝宝聂是念来过倒5 (审核中...)

前往app查看评论内容

#COPD#学习

2021 AAFP临床实践指南：COPD急性加重的药物治疗

2021-08-25

smart Ren (审核中...)

前往app查看评论内容

#COPD#布地奈德

2021-05-26

mswert122 (审核中...)

前往app查看评论内容

#COPD#320或160μg布地奈德+18μg格隆溴铵+9.6μg沙美特罗

NEJM：含布地奈德的三联方案可有效控制中重度COPD进展

2020-06-25

lovetcm (审核中...)

前往app查看评论内容

含#布地奈德#的三联方案可有效控制中重度#COPD#进展，未来LABA+LAMA方案应该是主流

NEJM：含布地奈德的三联方案可有效控制中重度COPD进展

2020-11-02

神盾医疗局局长Jack (审核中...)

前往app查看评论内容

#COPD#这是很好理解的

2020-06-11

科室
- - 订阅+
  - 更多科室
工具
服务